Latest European Markets News

Page 1 of 22
DataDot Technology Limited (ASX:DDT) delivered a stronger FY26, with revenue rising 14.1% to $3.85 million and profit before tax nearly tripling to $327,420. The sharper result was driven largely by PropertyVAULT’s first full year of insurance services, although key insurer relationships remain pilots or works in progress.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Skellerup says FY27 has begun strongly, with first-quarter net profit after tax up 15% on the prior comparative period. The NZX-listed industrial products maker is forecasting full-year NPAT of $67 million to $72 million, while warning that geopolitical unrest and higher costs could weigh on demand.
Victor Sage
Victor Sage
21 Oct 2026
Camplify Holdings generated $1.438 million in operating cash flow in the first quarter of FY27 and ended September with $11.333 million in cash and no debt. But GTV fell 27% year on year and forward bookings remained 17% below the prior corresponding period, leaving the summer booking cycle as the key test.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.
Ada Torres
Ada Torres
13 Oct 2026
Memphasys has signed a three-year exclusive distribution agreement covering the Czech Republic, Slovakia and Kazakhstan, with minimum purchases worth approximately A$674,000. The deal expands Felix’s European footprint while adding dedicated commercial leadership in the region.
Victor Sage
Victor Sage
18 Sept 2026
Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.
Ada Torres
Ada Torres
4 Sept 2026
Energy One Limited (ASX:EOL) reported a robust FY2026 with a 17% increase in recurring revenue and a 51% jump in net profit before tax, while preparing for a transformative acquisition of Gas Management Services Limited to deepen its European market presence.
Sophie Babbage
Sophie Babbage
2 Sept 2026
BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.
Victor Sage
Victor Sage
31 Aug 2026
AML3D Limited surged to a record $12.5 million revenue in FY26, delivering its first half-year EBITDA profit and locking in a $29 million order book driven by US Defence contracts and UK market entry.
Victor Sage
Victor Sage
31 Aug 2026
IODM Limited’s FY26 results show solid revenue gains led by UK education, but losses persist with a net deficiency in equity raising going concern questions.
Sophie Babbage
Sophie Babbage
31 Aug 2026
OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.
Ada Torres
Ada Torres
28 Aug 2026
SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.
Ada Torres
Ada Torres
28 Aug 2026

Browse the archive

Full archive